Korro Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Korro Bio and other ETFs, options, and stocks.

About KRRO

Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

CEO

Ram Aiyar

CEORam Aiyar

Employees

104

Employees104

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2018

Founded2018

Employees

104

Employees104

KRRO Key Statistics

Market cap

169.00M

Market cap169.00M

Price-Earnings ratio

-1.86

Price-Earnings ratio-1.86

Dividend yield

—

Dividend yield—

Average volume

116.11K

Average volume116.11K

High today

$18.09

High today$18.09

Low today

$16.44

Low today$16.44

Open price

$17.32

Open price$17.32

Volume

49.98K

Volume49.98K

52 Week high

$98.00

52 Week high$98.00

52 Week low

$11.13

52 Week low$11.13

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

Korro Bio

Why Robinhood?

Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. Show more

KRRO Key Statistics

Analyst ratings

100%

Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.